For up to date information regarding COVID-19 in South Africa, please visit sacoronavirus.co.za
Research Themes
-
HIV Treatment Outcomes and Guidelines
-
Linkage, Retention and Adherence for HIV Treatment in South Africa
-
Costs, Cost-Effectiveness and Benefits of HIV Care and Treatment
-
Tuberculosis and HIV in South Africa
-
Cost and Budget Modelling
-
Sexual and Reproductive Health
-
Primary Health Care
-
Non-Communicable Diseases
-
Research Capacity Building
Research Programs
-
Evaluations to Inform Decisions using Economics and Epidemiology (EVIDENCE)
-
Indlela: Behavioural Insights for Better Health
-
COVID-19 Response
-
Economic Impact of HIV
-
CETA
-
Innovations Research on AIDS (INROADS)
-
AMBIT: Alternative Models of ART Delivery – Optimizing the Benefits
-
Using routinely collected laboratory data to evaluate South Africa’s national HIV treatment program through a national HIV cohort
-
Journal Articles
Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a clusterrandomised, non-blinded, non-inferiority trial
Summary
Background: Facility-based, multimonth dispensing of antiretroviral therapy (ART) for HIV could reduce burdens on patients and providers and improve retention in care. We assessed whether 6-monthly ART dispensing was non-inferior to standard of care and 3-monthly ART dispensing. Methods: We did a pragmatic, cluster-randomised, unblinded, non-inferiority trial (INTERVAL) at 30 health facilities in ... -
Journal Articles
Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients
Abstract
Introduction: Lesotho, the country with the second-highest HIV/AIDS prevalence (23.6%) in the world, has made considerable progress towards achieving the “95-95-95” UNAIDS targets, but recent success in improving treatment access to all known HIV positive individuals has severely strained existing healthcare infrastructure, financial and human resources. Lesotho also faces the challenge of a ... -
Journal Articles
Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
Abstract
Background: Cryptococcal meningitis in HIV-infected patients in sub-Saharan Africa accounts for three-quarters of the global cases and 135,000 deaths per annum. Current treatment includes the use of fluconazole and amphotericin B. Recent evidence has shown that the synergistic use of flucytosine improves efficacy and reduces toxicity, however affordability and availability has hampered access ...
-
Vacancies
Senior/Principal Researcher – Health Economics
We seek a dynamic, enthusiastic, and self-motivated quantitative senior researcher to be part of our health economics research and implementation science portfolio. This portfolio focuses on the costs, cost-effectiveness, and benefits of healthcare interventions, health financing and health systems, and other priority public health challenges, with opportunities for both primary data collection and mathematical modeling. ...
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.
News
-
Indlela Request for Proposals: Behavioural Insights Tests (BITs)
...
-
HE2RO contributes to NDOH’s Covid-19 modelling
We are pleased to announce that we are now able to share the reports on the projections of the National Covid-19 Epi Model to which...
-
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID
HE2RO has been awarded a new 5-year Co-operative Agreement from USAID. This new program, the HIV/AIDS Economics and Research Activity, called EVIDENCE will run...
